A detailed history of Navalign, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Navalign, LLC holds 11,078 shares of PFE stock, worth $304,201. This represents 0.09% of its overall portfolio holdings.

Number of Shares
11,078
Previous 12,245 9.53%
Holding current value
$304,201
Previous $342,000 6.43%
% of portfolio
0.09%
Previous 0.11%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$27.7 - $31.39 $32,325 - $36,632
-1,167 Reduced 9.53%
11,078 $320,000
Q2 2024

Jul 30, 2024

BUY
$25.26 - $29.6 $18,111 - $21,223
717 Added 6.22%
12,245 $342,000
Q1 2024

Apr 12, 2024

SELL
$25.89 - $29.73 $69,721 - $80,062
-2,693 Reduced 18.94%
11,528 $319,000
Q4 2023

Jan 18, 2024

SELL
$26.13 - $33.94 $295,974 - $384,438
-11,327 Reduced 44.34%
14,221 $409,000
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $45,856 - $53,601
-1,429 Reduced 5.3%
25,548 $847,000
Q2 2023

Jul 14, 2023

SELL
$36.12 - $41.79 $81,992 - $94,863
-2,270 Reduced 7.76%
26,977 $989,000
Q1 2023

Apr 19, 2023

SELL
$39.39 - $51.28 $13,510 - $17,589
-343 Reduced 1.16%
29,247 $1.19 Million
Q4 2022

Feb 06, 2023

SELL
$41.75 - $54.5 $22,378 - $29,212
-536 Reduced 1.78%
29,590 $1.52 Million
Q3 2022

Nov 02, 2022

SELL
$43.76 - $53.42 $1,925 - $2,350
-44 Reduced 0.15%
30,126 $1.32 Million
Q2 2022

Jul 27, 2022

SELL
$46.53 - $55.17 $21,496 - $25,488
-462 Reduced 1.51%
30,170 $1.58 Million
Q1 2022

Apr 29, 2022

SELL
$45.75 - $56.69 $62,540 - $77,495
-1,367 Reduced 4.27%
30,632 $1.52 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $47,518 - $70,437
-1,150 Reduced 3.47%
31,999 $1.89 Million
Q3 2021

Nov 03, 2021

SELL
$39.25 - $50.42 $11,971 - $15,378
-305 Reduced 0.91%
33,149 $1.43 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $42,230 - $47,839
1,176 Added 3.64%
33,454 $1.31 Million
Q1 2021

May 10, 2021

BUY
$33.49 - $37.77 $1.08 Million - $1.22 Million
32,278 New
32,278 $1.17 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Navalign, LLC Portfolio

Follow Navalign, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navalign, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Navalign, LLC with notifications on news.